Contract development organisation (CRO) Huasky Medical has garnered $50 million in its Series C round, while Hong Kong-based Chinese CRO firm ZSHK Lab has raised 100 million yuan ($15 million) in its Series A round led by Qiming Venture Partners.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
